TY - JOUR
T1 - Delivery patterns of recommended chronic kidney disease care in clinical practice
T2 - Administrative claims-based analysis and systematic literature review
AU - Philipneri, Marie D.
AU - Rocca Rey, Lisa A.
AU - Schnitzler, Mark A.
AU - Abbott, Kevin C.
AU - Brennan, Daniel C.
AU - Takemoto, Steven K.
AU - Buchanan, Paula M.
AU - Burroughs, Thomas E.
AU - Willoughby, Lisa M.
AU - Lentine, Krista L.
N1 - Funding Information:
Ms. Buchanan received support from a Public Policy Fellowship from the American Society of Transplantation. Dr. Brennan received support from a grant from the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK), K24-DK002886. Dr. Lentine received support from a grant from the NIDDK, K08-DK073036. An abstract describing a portion of this work was presented at the American Society of Nephrology 39th Annual Renal Week Meeting on November 18, 2006, in San Diego, CA, USA.
Funding Information:
Funding Sources: Ms. Buchanan received support from a Public Policy Fellowship from the American Society of Transplantation. Dr. Brennan received support from a grant from the National Institute of Diabetes Digestive and Kidney Diseases (NIDDK), K24-DK002886. Dr. Lentine received support from a grant from the NIDDK, K08-DK073036.
PY - 2008/2
Y1 - 2008/2
N2 - Background: Clinical practice guidelines for management of chronic kidney disease (CKD) have been developed within the Kidney Disease Outcomes Quality Initiative (K/DOQI). Adherence patterns may identify focus areas for quality improvement. Methods: We retrospectively studied contemporary CKD care patterns within a private health system in the United States, and systematically reviewed literature of reported practices internationally. Five hundred and nineteen patients with moderate CKD (estimated GFR 30-59 ml/min) using healthcare benefits in 2002-2005 were identified from administrative insurance records. Thirty-three relevant publications in 2000-2006 describing care in 77,588 CKD patients were reviewed. Baseline demographic traits and provider specialty were considered as correlates of delivered care. Testing consistent with K/DOQI guidelines and prevalence of angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) medication prescriptions were ascertained from billing claims. Care descriptions in the literature sample were based on medical charts, electronic records and/or claims. Results: KDOQI-consistent measurements of parathyroid hormone (7.1 vs. 0.6%, P = 0.0002), phosphorus (38.2 vs. 1.9%, P < 0.0001) and quantified urinary protein (23.8 vs. 9.4%, P = 0.008) were more common among CKD patients with versus without nephrology referral in the administrative data. Nephrology referral correlated with increased likelihood of testing for parathyroid hormone and phosphorus after adjustment for baseline patient factors. Use of ACEi/ARB medications was more common among patients with nephrology contact (50.0 vs. 30.0%; P = 0.008) but appeared largely driven by higher comorbidity burden. The literature review demonstrated similar practice patterns. Conclusions: Delivery of CKD care may be monitored by administrative data. There is opportunity for improvement in CKD guideline adherence in practice.
AB - Background: Clinical practice guidelines for management of chronic kidney disease (CKD) have been developed within the Kidney Disease Outcomes Quality Initiative (K/DOQI). Adherence patterns may identify focus areas for quality improvement. Methods: We retrospectively studied contemporary CKD care patterns within a private health system in the United States, and systematically reviewed literature of reported practices internationally. Five hundred and nineteen patients with moderate CKD (estimated GFR 30-59 ml/min) using healthcare benefits in 2002-2005 were identified from administrative insurance records. Thirty-three relevant publications in 2000-2006 describing care in 77,588 CKD patients were reviewed. Baseline demographic traits and provider specialty were considered as correlates of delivered care. Testing consistent with K/DOQI guidelines and prevalence of angiotensin converting enzyme inhibitor/angiotensin receptor blocker (ACEi/ARB) medication prescriptions were ascertained from billing claims. Care descriptions in the literature sample were based on medical charts, electronic records and/or claims. Results: KDOQI-consistent measurements of parathyroid hormone (7.1 vs. 0.6%, P = 0.0002), phosphorus (38.2 vs. 1.9%, P < 0.0001) and quantified urinary protein (23.8 vs. 9.4%, P = 0.008) were more common among CKD patients with versus without nephrology referral in the administrative data. Nephrology referral correlated with increased likelihood of testing for parathyroid hormone and phosphorus after adjustment for baseline patient factors. Use of ACEi/ARB medications was more common among patients with nephrology contact (50.0 vs. 30.0%; P = 0.008) but appeared largely driven by higher comorbidity burden. The literature review demonstrated similar practice patterns. Conclusions: Delivery of CKD care may be monitored by administrative data. There is opportunity for improvement in CKD guideline adherence in practice.
KW - Angiotensin-converting enzyme inhibitors
KW - Chronic kidney disease
KW - Guideline adherence
KW - Laboratory diagnoses
KW - Physician's practice patterns
KW - Referral and consultation
UR - http://www.scopus.com/inward/record.url?scp=38549095675&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=38549095675&partnerID=8YFLogxK
U2 - 10.1007/s10157-007-0016-3
DO - 10.1007/s10157-007-0016-3
M3 - Article
C2 - 18175059
AN - SCOPUS:38549095675
SN - 1342-1751
VL - 12
SP - 41
EP - 52
JO - Clinical and Experimental Nephrology
JF - Clinical and Experimental Nephrology
IS - 1
ER -